Literature DB >> 15693871

Clinical characteristics of chronic lung disease without preceding respiratory distress syndrome in preterm infants.

Chang Won Choi1, Beyong Il Kim, Young Yull Koh, Jung-Hwan Choi, Jung Yun Choi.   

Abstract

BACKGROUND: Recently, the incidence of atypical presentation of chronic lung disease (CLD) that develops in infants without a history of preceding respiratory distress syndrome (RDS) is increasing. Therefore, the clinical characteristics of CLD without RDS in comparison with CLD with RDS were assessed.
METHODS: Prospective cohort analysis was done from 117 very low-birthweight infants who were born in Seoul National University Hospital and survived more than 36 weeks postmenstrual age (PMA).
RESULTS: Of the 117 infants analyzed, CLD developed in 44 infants (38%). Among these 44 infants, CLD with RDS developed in 27 infants (23%) and CLD without RDS developed in 17 infants (15%). Each type of CLD was subgrouped according to the presence of chorioamnionitis (CA): RDS(+)CA(+) CLD (n = 8) and RDS(+)CA(-) CLD (n = 19); and RDS(-)CA(+) CLD (n = 12) and RDS(-)CA(-) CLD (n = 5). There were no significant differences in the demographic characteristics between CLD with RDS and CLD without RDS. Chorioamnionitis was significantly more common in CLD without RDS, while patent ductus arteriosus was more common in CLD with RDS. Although the severity of initial respiratory failure was not greater than that of CLD with RDS, CLD without RDS showed a gradually increasing chronic oxygen requirement pattern. Chronic oxygen requirement pattern showed that infants with RDS(+)CA(+)CLD required the highest concentrations of oxygen not only initially but also thereafter until the 28th day of life and 36 weeks PMA.
CONCLUSIONS: Although CLD without RDS was still less common than CLD with RDS, it comprised over a third of all cases of CLD in our study. Clinical characteristics and chronic oxygen requirement pattern of CLD without RDS seems to be less severe than those of CLD with RDS. Our data suggest that CLD without RDS may be developed by causes other than initial acute lung injury. Chorioamnionitis may be one of antecedents of CLD without RDS.

Entities:  

Mesh:

Year:  2005        PMID: 15693871     DOI: 10.1111/j.1442-200x.2004.01996.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  6 in total

Review 1.  Bronchopulmonary dysplasia.

Authors:  Bernard Thébaud; Kara N Goss; Matthew Laughon; Jeffrey A Whitsett; Steven H Abman; Robin H Steinhorn; Judy L Aschner; Peter G Davis; Sharon A McGrath-Morrow; Roger F Soll; Alan H Jobe
Journal:  Nat Rev Dis Primers       Date:  2019-11-14       Impact factor: 52.329

2.  Patterns of respiratory disease during the first 2 postnatal weeks in extremely premature infants.

Authors:  Matthew Laughon; Elizabeth N Allred; Carl Bose; T Michael O'Shea; Linda J Van Marter; Richard A Ehrenkranz; Alan Leviton
Journal:  Pediatrics       Date:  2009-04       Impact factor: 7.124

Review 3.  Predictors of bronchopulmonary dysplasia.

Authors:  Andrea Trembath; Matthew M Laughon
Journal:  Clin Perinatol       Date:  2012-09       Impact factor: 3.430

4.  Neonatal Morbidities Associated with Histologic Chorioamnionitis Defined Based on the Site and Extent of Inflammation in Very Low Birth Weight Infants.

Authors:  Su Yeong Kim; Chang Won Choi; Euiseok Jung; Juyoung Lee; Jin A Lee; Haeryoung Kim; Ee-Kyung Kim; Han-Suk Kim; Beyong Il Kim; Jung-Hwan Choi
Journal:  J Korean Med Sci       Date:  2015-09-12       Impact factor: 2.153

5.  Gene expression profile of androgen modulated genes in the murine fetal developing lung.

Authors:  Eva Bresson; Tommy Seaborn; Mélissa Côté; Geneviève Cormier; Pierre R Provost; Bruno Piedboeuf; Yves Tremblay
Journal:  Reprod Biol Endocrinol       Date:  2010-01-08       Impact factor: 5.211

6.  Expression profile of androgen-modulated microRNAs in the fetal murine lung.

Authors:  Wafae Bouhaddioui; Pierre R Provost; Yves Tremblay
Journal:  Biol Sex Differ       Date:  2016-04-01       Impact factor: 5.027

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.